Document is current
Any future updates will be listed below
-
Authors
Aulin, L. B. S.
De Paepe, P.
Dhont, E.
de Jaeger, A.
Vande Walle, J.
Vandenberghe, W.
McWhinney, B. C.
Ungerer, J. P. J.
van Hasselt, J. G. C.
De Cock, P. A. J. G. https://orcid.org/0000-0001-7634-7471
-
Funding
Funding for this research was provided by:
Universitair Ziekenhuis Gent (WR/1294/APO/001)
Agentschap voor Innovatie door Wetenschap en Technologie (IWT/SBO/ 130033)
- License Information
-
More Information
Article History
Accepted: 16 September 2020
First Online: 8 October 2020
Declarations
:
: This work was supported by the Clinical Research Fund Ghent University Hospital, Ghent Belgium (grant number WR/1294/APO/001 to Pieter A. J. G. De Cock) and the Agency for Innovation by Science and Technology, Flanders, Belgium (SAFEPEDRUG project; grant number IWT/SBO/130033).
: Not applicable.
: The study was conducted in accordance with the guidelines of the Declaration of Helsinki, was approved by the institutional ethics committee (EC/2012/172), and was registered at ClinicalTrials.gov (NCT02456974).
: Written informed consent was obtained from the parents or legal representatives, and assent was obtained from patients aged older than 12 years.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
